Hygiena 2017, 62(1):18-23 | DOI: 10.21101/hygiena.a1494

Cardiovascular Diseases among Women

Liana Greiffeneggová1,2, Drahoslava Hrubá1
1 Masarykova univerzita, Lékařská fakulta, Ústav ochrany a podpory zdraví, Brno, Česká republika
2 Masarykova univerzita, Lékařská fakulta, Katedra porodní asistence a zdravotnických záchranářů, Brno, Česká republika

According to a number of epidemiological studies, women are more vulnerable to cardiovascular risk factors than men. Women also have certain specific risk factors such as use of oral hormone contraceptives, hormone replacement therapy, pregnancy and toxaemia during pregnancy. This paper describes former and recent results from significant studies on gender differences in cardiovascular morbidity and mortality.

Keywords: cardiovascular diseases, risk factors, females

Received: August 2016; Accepted: February 23, 2017; Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Greiffeneggová L, Hrubá D. Cardiovascular Diseases among Women. Hygiena. 2017;62(1):18-23. doi: 10.21101/hygiena.a1494.
Download citation

References

  1. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation. 1993 Oct;88(4 Pt 1):1999-2009. Go to original source... Go to PubMed...
  2. Eaker ED, Castelli WP. Coronary heart disease and its risk factors among women in the Framingham Study. In: Proceedings of an NIH Workshop. New York: Haymarket Doyma; 1987. p. 122-32.
  3. Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity. A reassessment. JAMA. 1987 Jan 16;257(3):353-8. Go to original source... Go to PubMed...
  4. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. Circulation. 1991 Feb;83(2):484-91. Go to original source... Go to PubMed...
  5. Marmor A, Geltman EM, Schechtman K, Sobel BE, Roberts R. Recurrent myocardial infarction: clinical predictors and prognostic implications. Circulation. 1982 Aug;66(2):415-21. Go to original source... Go to PubMed...
  6. Boogaard MAK, Briody ME. Comparison of the rehabilitation of men and women post-myocardial infarction. J Cardiopulm Rehabil. 1985;5(8):379-84. Go to original source...
  7. Epidemiology. In: National Heart, Lung, and Blood Institute. Report of the Task Force on Research in Epidemiology and Prevention of Cardiovascular Diseases. Rockville: National Institutes of Health; 1994. p. 19-72.
  8. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al.; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004 Sep 11-17;364(9438):937-52. Go to original source... Go to PubMed...
  9. Sørheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 2010 Jun;65(6):480-5. Go to original source... Go to PubMed...
  10. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998 Apr 4;316(7137):1043-7. Go to original source... Go to PubMed...
  11. Njølstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation. 1996 Feb 1;93(3):450-6. Go to original source... Go to PubMed...
  12. Peto R, Lopez AD, Boreham J, Thun M, Heath CJ. Mortality from smoking in developed countries 1950-2000; indirect estimates from national vital statistics. New York: Oxford University Press; 1994.
  13. Floderus B, Cederlöf R, Friberg L. Smoking and mortality: a 21-year follow-up based on the Swedish Twin Registry. Int J Epidemiol. 1988 Jun;17(2):332-40. Go to original source... Go to PubMed...
  14. Woodward M, Lam TH, Barzi F, Patel A, Gu D, Rodgers A, et al.; Asia Pacific Cohort Studies Collaboration. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol. 2005 Oct;34(5):1036-45. Go to original source... Go to PubMed...
  15. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011 Oct 8;378(9799):1297-305. Go to original source... Go to PubMed...
  16. Bähler C, Gutzwiller F, Erne P, Radovanovic D. Lower age at first myocardial infarction in female compared to male smokers. Eur J Prev Cardiol. 2012 Oct;19(5):1184-93. Go to original source... Go to PubMed...
  17. Grundtvig M, Hagen TP, German M, Reikvam A. Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men. Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):174-9. Go to original source... Go to PubMed...
  18. Herzog W, Aversano T. Gender differences in the effect of traditional cardiac risk factors on age at presentation with STEMI. Circulation. 2007 Oct 16;116 Suppl 16:317. Go to original source... Go to PubMed...
  19. Prescott E, Scharling H, Osler M, Schnohr P. Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study. J Epidemiol Community Health. 2002 Sep;56(9):702-6. Go to original source... Go to PubMed...
  20. Grundtvig M, Hagen TP, Amrud ES, Reikvam Å. Reduced life expectancy after an incident hospital diagnosis of acute myocardial infarction - effects of smoking in women and men. Int J Cardiol. 2013 Sep 10;167(6):2792-7. Go to original source... Go to PubMed...
  21. Pitsavos C, Panagiotakos DB, Chrysohoou C, Tzioumis K, Papaioanou I, Stefanadis C, et al. Association between passive cigarette smoking and the risk of developing acute coronary syndromes: the CARDIO 2000 study. Heart Vessels. 2002;16(4):127-30. Go to original source... Go to PubMed...
  22. U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta: U.S. Departmement of Health and Human Services; 2006.
  23. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al.; INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006 Aug 19;368(9536):647-58. Go to original source... Go to PubMed...
  24. Iversen B, Jacobsen BK, Løchen ML. Active and passive smoking and the risk of myocardial infarction in 24,968 men and women during 11 year of follow-up: the Tromsø Study. Eur J Epidemiol. 2013 Aug;28(8):659-67. Go to original source... Go to PubMed...
  25. Faught BE, Flouris AD, Cairney J. Epidemiological evidence associating secondhand smoke exposure with cardiovascular disease. Inflamm Allergy Drug Targets. 2009 Dec;8(5):321-7. Go to original source... Go to PubMed...
  26. Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation. 2009 Oct 6;120(14):1373-9. Go to original source... Go to PubMed...
  27. Flouris AD, Vardavas CI, Metsios GS, Tsatsakis AM, Koutedakis Y. Biological evidence for the acute health effects of secondhand smoke exposure. Am J Physiol Lung Cell Mol Physiol. 2010 Jan;298(1):L3-L12. Go to original source... Go to PubMed...
  28. Shah RS, Cole JW. Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther. 2010 Jul;8(7):917-32. Go to original source... Go to PubMed...
  29. Kurth T, Kase CS, Berger K, Gaziano JM, Cook NR, Buring JE. Smoking and risk of hemorrhagic stroke in women. Stroke. 2003 Dec;34(12):2792-5. Go to original source... Go to PubMed...
  30. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, et al. Smoking cessation and decreased risk of stroke in women. JAMA. 1993 Jan 13;269(2):232-6. Go to original source...
  31. Farley TM, Meirik O, Chang CL, Poulter NR. Combined oral contraceptives, smoking, and cardiovascular risk. J Epidemiol Community Health. 1998 Dec;52(12):775-85. Go to original source... Go to PubMed...
  32. Croft P, Hannaford PC. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. BMJ. 1989 Jan 21;298(6667):165-8. Go to original source... Go to PubMed...
  33. Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ. 1999 Jan 2;318(7175):13-8. Go to original source...
  34. Pomp ER, Rosendaal FR, Doggen CJ. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol. 2008 Feb;83(2):97-102. Go to original source... Go to PubMed...
  35. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med. 1991 Sep 12;325(11):756-62. Go to original source... Go to PubMed...
  36. Vessey M, Yeates D, Flynn S. Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception. 2010 Sep;82(3):221-9. Go to original source... Go to PubMed...
  37. Paoletti R, Bolego C, Poli A, Cignarella A. Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manag. 2006;2(2):145-52. Go to original source... Go to PubMed...
  38. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008 Apr;87(4):801-9. Go to original source... Go to PubMed...
  39. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care. 2002 Nov;25(11):2016-21. Go to original source... Go to PubMed...
  40. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000 Mar 23;342(12):836-43. Go to original source... Go to PubMed...
  41. Ahonen TM, Kautiainen HJ, Keinänen-Kiukaanniemi SM, Kumpusalo EA, Vanhala MJ. Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein. Am J Prev Med. 2008 Dec;35(6):598-601. Go to original source... Go to PubMed...
  42. Soška V, Fiala J, Nebeská K, Hrubá D. Sekundární dyslipidemie navozená současnými perorálními kontraceptivy. Vnitř Lék. 2009;55(10):929-33. Go to PubMed...
  43. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006 Oct;6(10):772-83. Go to original source... Go to PubMed...
  44. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998 Mar;83(3):847-50. Go to original source...
  45. Greiffeneggová L, Hrubá D. Kardiovaskulární změny v těhotenství. I. Těhotenství zvyšuje riziko nemocí srdce a cév. Prakt Gynekol. 2016;20(2):81-3.
  46. Roelands J, Jamison MG, Lyerly AD, James AH. Consequences of smoking during pregnancy on maternal health. J Womens Health (Larchmt). 2009 Jun;18(6):867-72. Go to original source... Go to PubMed...
  47. Greiffeneggová L, Hrubá D. Kardiovaskulární změny v těhotenství II. Preeklampsie a její pozdní následky pro matku a dítě. Prakt Gynekol. 2016;20(3-4):143-6.
  48. Kříž J. Zdravotní nerovnosti: staré problémy, nová řešení. Hygiena. 2015;60(2):39.
  49. Ministerstvo zdravotnictví ČR. Zdraví 2020: Národní strategie ochrany a podpory zdraví a prevence nemocí [Internet]. Praha: MZ ČR; 2014 [cit. 23. února 2017]. Dostupné z: http://www.mzcr.cz/dokumenty/zdravi-2020-narodni%20strategie-ochrany%20-a-podpory%20zdravi-a-prevence%20-nemoci_8663_114_1.html.
  50. Kotulán J. K účinnosti našich zdravotních programů. Hygiena. 2015;60(2):81-5. Go to original source...
  51. Wilhelmova R, Hruba D, Vesela L. Key Determinants influencing the health literacy of pregnant women in the Czech Republic. Zdr Varst. 2014 Dec 30;54(1):27-36. Go to original source...